PATTISON Affichage ouvre son appel aux candidatures pour la subvention Elevating Voices de 2024
15 févr. 2024 06h00 HE
|
PATTISON Outdoor Advertising LP
Photo ci-dessus : Murale numérique de Royal Bank Plaza, montrant une publicité pour The Forum, récipiendaire d’une subvention Elevating Voices MISSISSAUGA, Ontario, 15 févr. 2024 ...
PATTISON Outdoor Open to Applications for 2024’s Elevating Voices Grant
15 févr. 2024 06h00 HE
|
PATTISON Outdoor Advertising LP
Pictured above: Royal Bank Plaza Digital Wall, featuring an advertisement for The Forum, an Elevating Voices Grant recipient MISSISSAUGA, Ontario, Feb. 15, 2024 (GLOBE...
Vandria Awarded €3.8M in Prestigious Innosuisse and Eurostars Grants to Advance Innovative Drug Programs for Age-Related Diseases of the CNS and Muscle
08 févr. 2024 03h00 HE
|
Vandria
Vandria is advancing a portfolio of mitophagy inducers to address age-related chronic diseases of the CNS, muscle, lung and liverInnosuisse grant totalling CHF 2.5M (€2.7M) to support early clinical...
Yamaha Empowers E-Bike Communities with Groundbreaking Outdoor Access Initiative Grants
18 janv. 2024 15h00 HE
|
Yamaha Motor Corp., USA
MARIETTA, Ga., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Yamaha Motor Corp., USA, proudly announces a groundbreaking chapter in outdoor access with the Yamaha Outdoor Access Initiative (OAI) awarding two...
Water Mission Awarded $1 Million Grant from The Coca-Cola Foundation, Funding Safe Water Programming in Uganda and Tanzania
18 janv. 2024 08h59 HE
|
Water Mission
Water Mission, is partnering with The Coca-Cola Foundation on a safe water program grant that will benefit more than 53,000 people in Uganda and Tanzania.
La FDA Américaine Accorde la Qualification de Médicament Orphelin au PTX-252 pour le Traitement de la Leucémie Myéloïde Aiguë (LMA)
16 janv. 2024 13h30 HE
|
Hyloris Pharmaceuticals SA
La FDA Américaine Accorde la Qualification de Médicament Orphelin au PTX-252 pour le Traitement de la Leucémie Myéloïde Aiguë (LMA) Le PTX-252 (précédemment appelé agent plécoïdeTM) est une nouvelle...
Orphan Drug Designation Granted to PTX-252 by U.S. FDA for the Treatment of Acute Myeloid Leukaemia (AML)
16 janv. 2024 13h30 HE
|
Hyloris Pharmaceuticals SA
Orphan Drug Designation Granted to PTX-252 by U.S. FDA for the Treatment of Acute Myeloid Leukaemia (AML) PTX-252 (previously referenced as a Plecoid™Agent) is a novel molecular entity developed in...
ARC Opens Applications for 2024 Substance Use Disorder Recovery-to-Work Projects
08 janv. 2024 14h00 HE
|
Appalachian Regional Commission
Washington, DC, Jan. 08, 2024 (GLOBE NEWSWIRE) -- WASHINGTON, D.C., January 8, 2024—The Appalachian Regional Commission (ARC) issued a Notice of Solicitation of Applications for its Investments...
Operation Come Home provides a welcoming and warm place for youth, thanks to an Ontario Trillium Foundation grant
20 déc. 2023 08h26 HE
|
Operation Come Home
Operation Come Home provides a welcoming and warm place for youth, thanks to an Ontario Trillium Foundation grant
Novacium Awarded € 90,000 Grant Towards Work on Its Engineered SiOx Anode Battery Material
20 déc. 2023 07h30 HE
|
HPQ Silicon Inc.
MONTREAL, Dec. 20, 2023 (GLOBE NEWSWIRE) -- HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ) (OTCQB: HPQFF) (FRA: O08), a technology company specializing in green engineering of silica and...